For decades, the story of Alzheimer’s research has been dominated by a battle between amyloid-beta and tau amyloids, both of which can kill neurons and impact the brain’s abil ...

A surprising new study has uncovered over 200 misfolded proteins in the brains of aging rats with cognitive decline, beyond the infamous amyloid and tau plaques long blamed for Alzheimer’s. These ...

For decades, the story of Alzheimer's research has been dominated by a battle between A-beta and tau amyloids, both of which ...

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...

Unexpected mutations in blood stem cells may help protect against Alzheimer’s disease. A new study published in the journal ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

Scientists in Australia have discovered that a magnetic brain treatment already used for depression can boost the brain’s ...

New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins ...

Analyzing plasma samples from 197 cognitively impaired participants in the observational BIODEGMAR cohort at Hospital del Mar, Barcelona, first author Federica Anastasi found that the NULISA tests ...

Many scientists view Down’s syndrome as a genetic form of Alzheimer’s because the amyloid precursor protein (APP) gene lies on chromosome 21. The extra dose of APP in DS causes amyloid to amass in the ...